Tenable Acquires Cymptom Labs
Tenable has entered an agreement to acquire Cymptom Labs, an attack path management startup, for an undisclosed price.
Cymptom proactively measures the impact of risk by mapping all attack paths before they happen. The company’s platform maps critical risk to the MITRE ATT&CK framework using agentless data collection technology to visualize all viable attack paths continuously both on-premises and within the cloud.
Cymptom’s technology intentionally avoids installing agents or running simulations to provide organizations with simple deployment, immediate value and always-on, pre-emptive cyber resilience to support business initiatives.
The growing complexity of relying on both data center on-premises networks and cloud-based systems has challenged visibility. Cymptom delivers a consolidated view of a company’s security posture that requires only one tool to understand the most urgent mitigation needs.
Cymptom’s agentless platform will be integrated into Tenable’s threat and vulnerability data to provide an attack path visibility. The addition of attack path analysis will bring additional context and prioritization capabilities to Tenable’s platform, with a unified view of assets and vulnerabilities.
The acquisition of Cymptom is Tenable’s fourth in two years. Previous acquisitions include Alsid SAS for $98 million in February 2021.